Responses
Abstracts Accepted for Publication
Rheumatoid arthritis - anti-TNF therapy
AB0420 Secondary Efficacy Outcomes from a Phase 3 Study Support Clinical Equivalence Between BOW015 and Infliximab in Patients with Active Rheumatoid Arthritis on Stable Methotrexate Doses
Compose a Response to This Article
Other responses
No responses have been published for this article.